Abstract
Editors' Note: In response to the article “Hand postures in primary and secondary generalized tonic-clonic seizures,” Dr. Mintzer explains why the statistical methodology employed by the authors, Fisher exact test with Bonferroni correction for multiple comparisons, was not ideal and that the version for multiple groups would have been preferable. He also reinforces a point brought up in a previous comment by Dr. Lanska: multiple events from the same patient should not be considered independent for the purpose of statistical analysis. Authors Siegel and Tatum describe how they addressed the problem statistically. Authors Uruha et al. report that the myxovirus resistance A (MxA) polyclonal antibodies used in their study, “Sarcoplasmic MxA expression: A valuable marker of dermatomyositis,” have been discontinued by the company that produced them. The authors describe the results of their tests into the company's monoclonal antibody alternative, concluding that the alternative can be used comparably to the original, but may require higher concentrations. —Megan Alcauskas, MD, and Robert C. Griggs, MD Editors' Note: In response to the article “Hand postures in primary and secondary generalized tonic-clonic seizures,” Dr. Mintzer explains why the statistical methodology employed by the authors, Fisher exact test with Bonferroni correction for multiple comparisons, was not ideal and that the version for multiple groups would have been preferable.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.